<!DOCTYPE html>
<html lang="zh">
<head>
  <meta charset="UTF-8" />
  <title>胰岛素抵抗与肝脏脂肪代谢</title>
  <script type="module">
    import mermaid from 'https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.esm.min.mjs';
  mermaid.initialize({
    startOnLoad: true,
    theme: 'default',
    themeVariables: {
      fontSize: '20px' // 修改流程图字体大小
    }
  });
  </script>
  <style>
    body {
      font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
      background: #f4f4f4;
      margin: 0;
      padding: 0;
      color: #2c3e50;
      line-height: 1.6;
    }

    /* ===== 标题样式 ===== */
    .title-wrapper {
      background-color: #e0e0e0;
      padding: 2rem 1rem;
      text-align: center;
      border-bottom: 4px solid #3498db;
    }
    .title-wrapper h2 {
      font-size: 2.2rem;
      color: #2c3e50;
      margin: 0;
      font-weight: 700;
    }

    /* ===== Mermaid 样式 ===== */
    .content {
      padding: 2rem 1rem;
      max-width: 900px;
      margin: 0 auto;
    }

    .mermaid {
      background: transparent;
      padding: 0;
      border-radius: 0;
      box-shadow: none;
      margin-bottom: 2rem;
    }
    .mermaid svg {
      background-color: transparent !important;
    }

    /* ===== 总结和参考文献容器样式 ===== */
    .info-box {
      background-color: #fff;
      border: 1px solid #ddd;
      border-radius: 8px;
      padding: 2rem 2.5rem;
      box-shadow: 0 2px 6px rgb(0 0 0 / 0.1);
      max-width: 900px;
      margin: 0 auto 3rem auto;
      color: #34495e;
	  border-left: 4px solid #3498db;  /* 加这行 */
    }

    /* 总结部分 - 严格按照官网字体、颜色、大小 */
    .info-box .summary {
      margin-bottom: 2rem;
      font-size: 16px;
      color: #222222;
      line-height: 1.5;
    }
    .info-box .summary strong {
      display: block;
      font-weight: 600;
      font-size: 1.25rem;
      margin-bottom: 1rem;
      color: #2c3e50;
    }
    .info-box .summary ul {
      padding-left: 1.5em;
      margin: 0;
      list-style-type: disc;
    }
    .info-box .summary ul li {
      margin-bottom: 0.5rem;
    }

    /* 参考文献部分 - 严格按照官网字体、颜色、大小 */
    .info-box .references {
      font-size: 16px;
      color: #555555;
      line-height: 1.5;
    }
    .info-box .references strong {
      color: #2c3e50;
      display: block;
      margin-bottom: 0.8rem;
      font-weight: 600;
      font-size: 1.1rem;
    }
    .info-box .references p {
      margin: 0.3rem 0;
    }
  </style>
</head>
<body>

  <div class="title-wrapper">
    <h2>胰岛素抵抗与肝脏脂肪代谢</h2>
  </div>

  <div class="content">
    <div class="mermaid">
graph TD
  A[内脏脂肪↑（脂肪细胞肥大 + 炎症）]
  A --> B[释放大量游离脂肪酸（FFA）↑]
  B --> C[FFA经门静脉进入肝脏]

  C --> D[部分FFA氧化供能]
  C --> E[多余FFA → 合成甘油三酯（TG）]
  E --> F[TG↑ → 极低密度脂蛋白（VLDL）↑]

  F --> G[VLDL将TG运往外周组织]
  G --> H[腹部脂肪储存TG → 腹部脂肪↑（大肚子）]
  H --> I[长期导致皮下 + 内脏脂肪双重积聚]
  F --> J[VLDL过多 → 动脉粥样硬化风险↑]

  C --> K[肝脏回收胆固醇（HDL介导）]
  K --> L[HDL回收外周胆固醇 → 返回肝脏]
  L --> M[胆固醇用于合成VLDL或排泄入胆汁]

  E --> N[肝脂积聚 → 脂肪肝]
  N --> O[干扰胰岛素信号传导]
  O --> P[促进糖异生↑ 胰岛素抵抗↑]
  P --> Q[胰岛素抵抗↑]

  Q --> R1[胰岛素抑制脂解作用↓]
  R1 --> R[脂肪储存能力↓（特别是皮下脂肪）]
  R --> S[脂肪组织功能恶化：炎症↑ 分化受限（脂肪细胞只长个头，不长数量）]
  S --> T[FFA释放进一步增加]
  T --> B

  style A fill:#f9f9f9,stroke:#999,stroke-width:1px
  style N fill:#fbe4d5
  style Q fill:#fde9d9
  style S fill:#fcd5ce
  style F fill:#e0f3ff
  style G fill:#e0f3ff
  style H fill:#e0f3ff
    </div>

    <section class="info-box">
      <div class="summary">
        <strong>总结：胰岛素抵抗让游离脂肪酸升高，导致脂肪代谢混乱和肝脏脂肪堆积</strong>
        <ul>
          <li>内脏脂肪增多会释放大量游离脂肪酸（FFA），通过门静脉进入肝脏。</li>
          <li>肝脏将多余的FFA合成为甘油三酯（TG），进而形成极低密度脂蛋白（VLDL）运往全身，导致脂肪堆积和动脉粥样硬化风险上升。</li>
          <li>多余脂肪在肝脏积聚形成脂肪肝，干扰胰岛素信号传导，进一步加剧胰岛素抵抗。</li>
          <li>胰岛素抵抗使脂肪更难储存，脂肪组织功能下降，炎症上升、细胞分化受限，进一步释放FFA，最终形成一个不断恶化的代谢恶性循环。</li>
        </ul>
      </div>

      <div class="references">
        <strong>参考文献</strong>
        <p>Gencer Sancar, Birkenfeld AL. The role of adipose tissue dysfunction in hepatic insulin resistance and T2D. Journal of Endocrinology. 2024.</p>
        <p>Snel M, et al. From excess adiposity to insulin resistance: the role of free fatty acids. Diabetes Care. 2012.</p>
        <p>Krauss RM. Fat depots, free fatty acids, and dyslipidemia. Current Opinion in Lipidology. 2013.</p>
        <p>Guilherme A, et al. Adipose tissue dysfunction and the pathogenesis of metabolic syndrome. World Journal of Diabetes. 2012.</p>
        <p>Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Current Diabetes Reports. 1999.</p>
      </div>
    </section>
  </div>

</body>
</html>
